Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,000
NCT02522221
Tecarfarin Anti-Coagulation Trial (TACT)
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 1, 2018
Completion: Jul 1, 2019